Companies with a Value score of at least 3, ordered by Value score

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
NTR	€0.93	0.5%	11.6%	€209.9m	€1.13	8.2	67.3%	n/a	Pharmaceuticals & Biotech
LXI	€379.00	0%	n/a	€14.5b	€461.98	18.4	10.7%	1.3%	Capital Goods
INR	US$14.67	6.7%	7.2%	US$915.2m	US$22.63	5.4	58.2%	n/a	Energy
NBCL.F	US$19.57	-5.5%	n/a	US$577.0b	US$32.32	13.0	-6.9%	0.9%	Capital Goods
C2H	€108.90	-6.8%	11.7%	€5.3b	€151.44	8.4	17.1%	5.3%	Transportation
GFT	€23.10	5.0%	34.0%	€582.9m	€30.23	16.0	15.5%	2.2%	Software
MX6A	€0.56	0.9%	-46.2%	€19.2b	€1.22	15.5	17.3%	3.1%	Pharmaceuticals & Biotech
PRUL	UK£10.15	-0.02%	0.9%	UK£25.1b	UK£14.21	8.6	-0.3%	1.9%	Insurance
UNC	€219.00	0.4%	11.9%	€41.5b	€286.70	18.9	13.8%	0.7%	Pharmaceuticals & Biotech
GFF	US$100.13	-5.5%	38.5%	US$4.7b	US$125.57	20.6	14.7%	0.9%	Capital Goods
2Y11	€0.98	-1.5%	-21.3%	€160.8b	€1.22	10.3	9.9%	5.8%	Telecom
HHH	US$67.93	0.3%	-6.5%	US$4.0b	US$89.67	13.8	12.4%	n/a	Real Estate Management and Development
FRGR	€7.74	-4.2%	-14.5%	€707.6m	€11.36	14.0	7.7%	4.3%	Transportation
PLOW	US$41.11	-1.9%	26.1%	US$960.7m	US$54.00	18.4	17.2%	2.9%	Capital Goods
RM	US$33.33	2.0%	-10.1%	US$309.6m	US$43.83	6.6	9.7%	3.6%	Diversified Financials
GTBI.F	US$7.51	2.7%	-11.9%	US$2.3b	US$15.30	12.8	-16.4%	n/a	Pharmaceuticals & Biotech
YALA	US$5.53	2.0%	-28.8%	US$836.6m	US$7.88	6.1	8.5%	n/a	Media
LX6	€2.52	3.3%	-30.4%	€1.8b	€3.24	18.8	24.7%	0%	Capital Goods
SGRY	US$13.94	-8.2%	-39.0%	US$1.8b	US$18.73	0.5	125.8%	n/a	Healthcare
BOWLL	UK£2.77	-0.9%	9.5%	UK£458.1m	UK£3.94	13.7	10.1%	4.8%	Consumer Services
PNT	€56.26	-1.1%	-37.7%	€10.5b	€67.61	16.0	12.3%	1.7%	Capital Goods
LMO	€316.00	-3.1%	20.6%	€8.2b	€381.34	11.4	12.8%	0.8%	Retail
8FN	€0.40	-1.2%	11.5%	€198.3m	€0.58	2.6	0.5%	5.0%	Transportation
0MGJ	€64.00	-2.1%	7.0%	€2.9b	€87.73	9.9	4.6%	3.1%	Materials

Potentially Undervalued Companies